Introduction {#S1}
============

Nasal polyp (NP) is a chronic inflammatory disease of the upper respiratory tract; however, its pathophysiology remains poorly understood. There are no aetiological factors that explain the pathogenesis of NPs, though inflammation continues to be a major factor [@R01] [@R02]. Many studies have noted that histopathological abnormities of NP are closely related to the infiltration of inflammatory cells. As a result of inflammation, neutrophils activate and migrate to the inflammatory area and exert their bactericidal effects by producing reactive oxygen species (ROS) [@R03]^-^[@R07]. Once the balance between ROS production and antioxidative defense activity is disrupted, oxidative stress can occur that may result in cell injury or death, subsequent tissue damage and, finally, chronic disease [@R08]^-^[@R10].

Studies investigating the role of ROS and antioxidants in nasal polyposis have found strong evidence for the involvement of oxidative stress in the pathogenesis of the condition [@R07] [@R11]^-^[@R23]. However, several of the oxidants and antioxidant enzymes that were evaluated in these studies may not be sufficient to accurately quantify oxidative stress. To clarify the results of these studies, we examined patients who underwent endoscopic surgery for NPs and assessed oxidative stress using a more valid and reliable method that measures total oxidant status (TOS) and total antioxidant status (TAS) both in serum and tissue.

Material and methods {#S2}
====================

Study design and patients {#S2a}
-------------------------

This cross-sectional study was conducted at the Otolaryngology Head and Neck Surgery Department of Harran University School of Medicine, Sanliurfa, Turkey. Prior to subject recruitment, the study protocol was reviewed and approved by the University\'s ethics committee, in accordance with the ethical principles for human investigations, as outlined by the Second Declaration of Helsinki. Written informed consent was obtained from all patients. From May 2010 to March 2011, 73 consecutive patients with NPs, septal deviations and middle concha hypertrophies were recruited for the study.

Patients were divided in two groups; group 1 (n = 38) consisted of patients with NPs, and group 2 (n = 35) was composed of patients with septal deviations and middle concha hypertrophies with computed tomography (CT) scores comparable to those of the study population. The diagnosis was based on anterior rhinoscopy, endoscopic examination and paranasal sinus CT. Findings on preoperative CT were graded according to the Lund--Mackay system. The mucosal abnormalities were graded as 0 (no abnormality), 1 (partial opacification), or 2 (total opacification) for each sinus group. The ostiomeatal complexes were scored bilaterally as 0 (not occluded) or 2 (occluded). The maximal CT grading score was 24 [@R24]. Polyp specimens were taken from all patients who underwent endoscopic surgery for NPs, and control specimens (mucosal punctates from lateral lamella of the middle turbinate) were acquired from patients who underwent an operation for septoplasty or middle concha hypertrophy.

The exclusion criteria included the following: recent acute infectious illness; any evidence of liver, kidney, or respiratory disease; diabetes mellitus; malignancy; any inflammatory or infiltrative disorder; recent use (within 2 weeks) of any systemic or local drug with antioxidant properties; preoperative drug use such as parenteral or oral corticosteroids and antibiotics for at least 4 weeks prior to sampling; and regular alcohol use or alcohol use within the previous 48 hours. No patient had a history of nasal allergy, asthma, or acetylsalicylic acid sensitivity. All showed negative results to a skin prick test with common airborne allergens, which was evaluated by the same experienced dermatologist to prevent interobserver variability. During interventions, tissue samples from polyps and turbinates were collected, fixed in formalin and frozen (-80° C) until the date of analysis.

Biochemical analysis {#S2b}
--------------------

All blood samples were drawn after a 12-hour overnight fasting from a large antecubital vein without interruption of venous flow using a 19-gauge butterfly needle connected to a plastic syringe. Twenty ml of blood was drawn, with the first few ml being discarded. Ten ml were used for baseline routine laboratory tests. The residual content of the syringe was transferred immediately to polypropylene tubes, which were then centrifuged at 3,000 rpm for 10 min at 10 to 18°C. Supernatant plasma samples were stored in plastic tubes at --80°C until assayed. As serum markers of oxidant stress, TOS was measured and the oxidative stress index (OSI) was calculated. TAS was measured as an indicator of antioxidant status. These parameters were also studied and calculated in tissues. Tissues were homogenized in saline solution using a homogenizer. After centrifugation at 10,000 g for approximately 60 min, the clear supernatant was taken. TAS and TOS were measured in this fraction and OSI was calculated.

Measurement of total oxidant status {#S2c}
-----------------------------------

Serum TOS was measured using a novel automated method developed by Erel [@R25]. Oxidants present in the sample oxidize the ferrous ion-o-dianisidine complex to ferric ion. The oxidation reaction is enhanced by glycerol molecules, which are abundantly present in the reaction medium. The ferric ion generates a colored complex with xylenol orange in an acidic medium. The colour intensity, which can be measured spectrophotometrically (V-530; Jasco®, Tokyo, Japan), is related to the quantity of oxidant molecules present in the sample. The assay is calibrated with hydrogen peroxide, and the results are expressed in terms of micromolar hydrogen peroxide equivalents per liter (µmol H~2~O~2~ equiv/l).

Measurement of total antioxidant status {#S2d}
---------------------------------------

Serum TAS was measured using a novel automated method developed by Erel [@R26]. In this technique, hydroxyl radical, the most potent biological radical, is produced. In the assay, the ferrous ion solution in reagent 1 is mixed with the hydrogen peroxide present in reagent 2. Sequentiallyproduced radicals, such as the hydroxyl radical-produced brown-colored dianisidinyl radical cation, are also potent radicals. This method allows the measurement of the sample\'s antioxidative effect against potent free radical reactions that are initiated by the hydroxyl radical. The assay has excellent precision values of more than 97%. The results are expressed as mmol Trolox equiv/l.

Oxidative stress index {#S2e}
----------------------

The OSI was defined as the ratio of TOS to TAS level. A standardized value does not exist for OSI levels, which were used only for comparisons. For the calculation, TAS units were changed to mmol/l, and the OSI value was calculated according to the following formula: OSI (arbitrary unit) = TOS (µmol H~2~O~2~ equiv./l)/TAS (mmol Trolox equiv/l) [@R25] [@R26].

Other variables {#S2f}
---------------

Serum urea, creatinine, fasting blood glucose, aspartate aminotransferase, alanine aminotransferase, triglycerides, total cholesterol, and high-density and low-density lipoprotein cholesterol levels were determined using commercially available assay kits (Abbott®, Abbott Park, North Chicago, Illinois, USA) with an auto-analyzer (Abbott®, Abbott Park, North Chicago, Illinois, USA).

Statistical analysis {#S2g}
--------------------

All statistical analyses were performed using SPSS for Windows version 17.0 (SPSS, Chicago, IL, USA). The Kolmogorov-Smirnov test was used to test the normality of data distribution. The data were expressed as arithmetic means and standard deviations. The chi-square test was used to compare categorical variables between groups. The independent sample T-test and Mann Whitney-U tests were used to compare continuous variables between the two groups. One-way ANOVA with a post-hoc Bonferroni test was used in normally distributed continuous data between all groups. Pearson\'s and Spearman\'s rank correlation analyses were used to examine the association of demographic and biochemical variables with oxidative stress parameters in group 1. A two-sided p value \< 0.05 was considered statistically significant.

Results {#S3}
=======

The biochemical and demographic characteristics of all patients are presented in [Table I](#T1){ref-type="table"}. There were no significant differences in gender, age or biochemical values in the two groups (p \> 0.05 for all). Renal and the liver function tests, cholesterol, triglyceride levels, and the CT scores were similar between the two groups.

###### 

Comparison of demographic and biochemical characteristics.

  ---------------------------------------------------------------------
                              Group 1\         Group 2\         p
                              (n = 38)         (n = 35)         
  --------------------------- ---------------- ---------------- -------
  Gender, male/female         17/21            16/19            NS^a^

  Age, years                  38.68 ± 8.44     36.26 ± 8.48     NS^b^

  Glucose, mg/dL              82.20 ± 10.20    79.00 ± 9.76     NS^b^

  CT scores                   13.37 ± 2.85     12.29 ± 2.55     NS^b^

  Urea, mg/dL                 25.24 ± 6.18     23.49 ± 4.46     NS^b^

  Creatinine, mg/dL           0.68 ± 0.25      0.71 ± 0.22      NS^b^

  ALT, U/mL                   24.03 ± 4.54     25.17 ± 3.75     NS^b^

  AST, U/mL                   26.15 ± 5.48     25.43 ± 5.88     NS^b^

  Total cholesterol, mg/dL    202.13 ± 24.54   194 ± 36.22      NS^c^

  LDL cholesterol, mg/dL      131.70 ± 36.93   141.70 ± 32.82   NS^c^

  Triglyceride level, mg/dL   205.16 ± 55.46   197.32 ± 61.37   NS^c^
  ---------------------------------------------------------------------

All measurable values are given as the mean ± standard deviation. NS: non-significant, CT: computed tomography, ALT: alanine aminotransferase, AST: aspartate aminotransferase, LDL: low-density lipoprotein

Chi-square^a^, independent sample T test^b^ and Mann Whitney-U^c^ tests were used

###### 

Comparison of oxidative stress parameters in all patients.

  ----------------------------------------------------------------------------------
                                         Group 1\        Group 2\        p
                                         (n = 38)        (n = 35)        
  ---------------------------- --------- --------------- --------------- -----------
  TOS, µmol H~2~O~2~ equiv/l   Serum\    21.34 ± 5.98\   17.38 ± 4.14\   \< 0.001\
                               Tissue\   28.59 ± 3.98\   16.72 ± 2.49\   \< 0.001
                               p         \< 0.001        \> 0.05         

  TAS, mmol Trolox equiv/l     Serum\    0.94 ± 0.14\    1.10 ± 0.14\    \< 0.001\
                               Tissue\   0.13 ± 0.03\    1.16 ± 0.12\    \< 0.001
                               p         \< 0.001        \> 0.05         

  OSI, arbitrary unit          Serum\    2.33 ± 0.65\    1.89 ± 0.45\    \< 0.001\
                               Tissue\   3.12 ± 0.43\    1.76 ± 0.29\    \< 0.001
                               p         \< 0.001        \> 0.05         
  ----------------------------------------------------------------------------------

All measurable values are given as the mean ± standard deviation.

TOS: total oxidant status, TAS: total antioxidant status, OSI: oxidative stress index

One-way ANOVA with a post-hoc Bonferroni\* test was used

Comparison of total antioxidant status levels {#S3a}
---------------------------------------------

Compared to group 2, group 1 had significantly lower TAS levels both in serum and tissues (both p \< 0.001). In group 1, tissue TAS levels were significantly lower than in serum (p \< 0.001). In group 2, there was no significant difference in TAS levels either in serum or tissues (p = 0.208).

Comparison of total oxidant status and oxidative stress index levels {#S3b}
--------------------------------------------------------------------

Compared to group 2, group 1 had significantly higher TOS and OSI levels both in serum and tissues (both p \< 0.001). In group 1, the TOS and OSI levels were significantly higher in tissue than in serum (p \< 0.001 for all). In group 2, there was no significant difference in the TOS or OSI levels either in serum or tissues (both p = 1.0). All OSI levels in serum and tissue are presented in [Figure 1](#F1){ref-type="fig"}.

![Oxidative stress index levels in serum and tissue.](0392-100X-33-248-g001){#F1}

In bivariate analysis, the serum OSI levels were significantly correlated with age in group 1 (r = 0.442, p = 0.005) ([Fig. 2](#F2){ref-type="fig"}). However, no significant correlations were observed between oxidative stress parameters and gender, serum fasting glucose, lipid parameters, urea, creatinine, AST or ALT levels (p \> 0.05 for all).

![Relationship between serum oxidative stress index and age (r = 0.442, p = 0.005).](0392-100X-33-248-g002){#F2}

Discussion {#S4}
==========

The main findings of this study are summarized as follows: (i) oxidative stress both in serum and tissues of patients with NPs was higher than in patients without NPs, (ii) serum OSI levels were significantly correlated with age and (iii) our study was able to provide important new insights and data because it assessed oxidative stress parameters using a more reliable method that measures both TOS and TAS.

Measuring different oxidant and antioxidant molecules is impractical, and oxidant and antioxidant effects are additive. Because there are numerous oxidants and antioxidants in the body, measuring total oxidant-antioxidant status is more valid and reliable. When only a few parameters are measured, levels may remain unchanged or decrease, even though the actual oxidant status increased or vice versa [@R25]^-^[@R27]. In the light of this information, we used TOS and TAS levels in our study.

ROS are suspected to have a major function in the pathogenesis of NPs [@R07] [@R11]^-^[@R23]. Studies have reported similar results, showing an increase in oxidative stress markers and deterioration in antioxidant scavenging systems. These studies provide strong evidence that oxidative stress plays a role in the pathogenesis of NPs [@R12]. Dogru et al. and Uneri et al. investigated the role of ROS in the development of NPs and reported that ROS may play a significant role in the pathogenesis of NPs [@R07] [@R13]. Dagli et al. compared 31 patients and 19 control subjects to investigate the role of ROS and antioxidants in NPs, and showed that the increase in MDA was higher in NP tissue and the blood of patients with NPs than in a concha bullosa group [@R18]. According to their results, in polyp tissue, the levels of an oxidant (malondialdehyde) were increased, and the levels of antioxidants (glutathione and α-tocopherol) were decreased compared with control tissues from inferior turbinates. In another study performed by Okur et al., the investigators demonstrated the production of ROS in the neutrophils of NPs and determined a very high ratio of ROS production in NPs [@R19]. Uneri at al. also reported high ROS levels in NP samples and showed a strong relationship between tissue damage and NP. Moreover, Cheng et al. studied the expression of superoxide dismutase 1 and 3 and found higher levels in polyp tissues. Such investigations indicate that ROS may be important in the pathogenesis of NP [@R13] [@R14].

Recent studies have also confirmed the role of oxidative stress in the development of NPs. Park et al. suggested the possibility that \[6\]-gingerol may play an important role in inhibiting the production of the extracellular matrix in the development of NPs through an antioxidant effect [@R28]. The same authors performed another study and showed that nicotinamide adenine dinucleotide phosphate oxidase and ROS have a role in myofibroblast differentiation and collagen production of transforming growth factor-β1-induced nasal polyp-derived fibroblasts, and that these processes are inhibited by the elimination of ROS [@R29]. Moon et al. have also demonstrated the ROS derived from NADPH oxidases, and transforming growth factor-β-1 have been implicated in the pathogenesis of hypoxia-induced NPs [@R30]. As confirmation, Jeanson et al. have shown the existence of an unfolded protein response in nasal epithelial cells that is linked to oxidative stress leading to interleukin-8 and leukotriene-B4 secretions. They concluded that these mechanisms may participate in chronic inflammation in NPs [@R31]. In our study, oxidative stress both in serum and tissue in patients with NPs was higher than in patients without NPs. Our study results on tissue and serum samples support the previous studies as it provides a more reliable quantification of oxidative stress parameters.

The frequency of NPs increases with age and seems to occur more often in men. The prevalence of this condition increases with age in both sexes to reach a peak in those aged 50 years or older. In the aging process, ROS production increases, while degradation is impaired, and thus oxidative stress accumulates [@R32]^-^[@R34]. In our study, serum OSI levels were significantly correlated with age but not correlated with gender in patients with NPs. Although not definitive, our study suggests that the increase in oxidative stress inherent in the aging process may contribute to the formation of NPs.

Conclusions {#S5}
===========

The findings of the present study demonstrate that oxidative stress is increased in patients with NPs. The important therapeutic potential to repair the harmful effects of oxidative stress on nasal tissues with antioxidant agents will only emerge with an improved understanding of the role of oxidative stress in NPs. The sample size was relatively small, and the design of the study was cross-sectional which are limitations of the present study. Therefore, large, prospective cohort studies are needed to address this issue.

This study was conducted at the Otolaryngology Head and Neck Surgery, Internal Medicine, Dermatology and Biochemistry Departments of Harran University School of Medicine, Sanliurfa. This study was approved by the Institutional Review Board.
